Tumor News and Research

RSS

Texas A&M researchers win NIH grant to study metabolism in people with Down syndrome

A team of researchers at the Texas A&M University School of Veterinary Medicine & Biomedical Sciences (VMBS) has received a grant from the National Institutes of Health (NIH) to research metabolism in people with Down syndrome.

17 Oct 2023

Research paves the way for new approach to tackling treatment resistance in cancer

Researchers at the University of California San Diego have discovered a process in which liver cells share molecules via vesicle exchange in order to multiply under conditions that would ordinarily suppress cell proliferation.

17 Oct 2023

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Laura Kuett, a Ph.D. student in Systems Biology, about the promise of 3D Imaging Mass Cytometry.

17 Oct 2023

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Whether inflammatory bowel disease (IBD) is causally related to extracolonic cancers.

17 Oct 2023

Impact of ketogenic diets on breast cancer

The therapeutic potential of the ketogenic diet (KD) for breast cancer (BC).

17 Oct 2023

Fluorescence lifetime imaging shows promise for improved tumor detection

Removing a patient's tumor while sparing healthy tissue requires exquisite precision, but often surgeons must rely on their eyes and hands to determine where to cut.

16 Oct 2023

Biochemists reveal how to prevent cancer cells from becoming resistant to chemotherapy

Biochemists from RUDN University described how to prevent cancer cells from becoming resistant to chemotherapy drugs.

16 Oct 2023

Finding the correlation between cancer and stroke risk

Patients with a previous or current cancer diagnosis are more likely to have a stroke than the general population, but how are specific cancers and treatments associated with stroke risk?

16 Oct 2023

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine ("Insilico") has been invited to present scientific data on its novel anti-cancer assets at three major upcoming cancer conferences -- the European Society for Medical Oncology (ESMO) conference in Madrid Oct. 20-24, 2023; the Society of Immunotherapy of Cancer (SITC) conference Nov. 1-5, 2023 in San Diego; and the San Antonio Breast Cancer Symposium (SABCS) Dec. 5-9, 2023.

16 Oct 2023

Researchers create new method for better 3D modeling of complex cancers

An international team of interdisciplinary researchers has successfully created a method for better 3D modelling of complex cancers.

16 Oct 2023

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of CNS malignancies.

16 Oct 2023

New radio-theranostics approach shows promise in the fight against pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide, with a 5-year survival rate of less than 10%. Many PDAC tumors in early stage go undetected because they are not found using conventional imaging methods, including fluorodeoxyglucose positron emission tomography (PET) scans.

15 Oct 2023

UCLA receives grant to improve liquid biopsy for early lung cancer detection

A team of investigators from the UCLA Jonsson Comprehensive Cancer Center and the UCLA School of Dentistry received a five-year $4.6 million grant from the National Cancer Institute to develop and improve liquid biopsy technologies for the early detection of lung cancer - the leading cause of cancer death in both men and women in the U.S.

13 Oct 2023

Nongenetic mechanisms play a role in lung cancer treatment resistance

In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and other institutions found that nongenetic mechanisms are important in lung cancer patients who develop a resistance to one cancer therapy.

13 Oct 2023

Tumor debulking does not impact quality of life in metastatic colorectal cancer, study finds

New research in the October 2023 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as "debulking"), in addition to standard systemic therapy, does not impact overall quality of life significantly for people with metastatic colorectal cancer.

13 Oct 2023

UTHealth Houston clinical trial therapy shrinks tumor of pancreatic cancer patient

Demetrios Stroubakis, 55, thought he was having a gallbladder attack when he arrived at the emergency room in August 2021 with jaundice. Instead, he was shocked to be diagnosed with pancreatic cancer.

13 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

In a recent review published in Immunity, researchers reviewed tumor-immunity cycle data.

13 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

Engineered bacteria deliver synthetic targets to solid tumors

For several years, researchers have been successfully using chimeric antigen receptor (CAR) T cells to target specific antigens found on blood cells as a cure for patients with leukemia and lymphoma.

12 Oct 2023

Tumor News and Research

Texas A&M researchers win NIH grant to study metabolism in people with Down syndrome

Research paves the way for new approach to tackling treatment resistance in cancer

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Impact of ketogenic diets on breast cancer

Fluorescence lifetime imaging shows promise for improved tumor detection

Biochemists reveal how to prevent cancer cells from becoming resistant to chemotherapy

Finding the correlation between cancer and stroke risk

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Researchers create new method for better 3D modeling of complex cancers

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

New radio-theranostics approach shows promise in the fight against pancreatic cancer

UCLA receives grant to improve liquid biopsy for early lung cancer detection

Nongenetic mechanisms play a role in lung cancer treatment resistance

Tumor debulking does not impact quality of life in metastatic colorectal cancer, study finds

UTHealth Houston clinical trial therapy shrinks tumor of pancreatic cancer patient

Are migraines linked to gut health and chronic non-communicable diseases?

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

Engineered bacteria deliver synthetic targets to solid tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News